Who owns Adaptive Biotechnologies Corp (ADPT)? Elite investor 13F holders
7 tracked elite investors reported holding Adaptive Biotechnologies Corp as of 2026-06-30, including Viking Global Investors, D.E. Shaw, Tudor Investment, Renaissance Technologies LLC, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Viking Global Investors | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 643365037.00 USD | 29993708.000000 | Shares | hold | Original filing |
| D.E. Shaw | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 99224675.00 USD | 4625859.000000 | Shares | add | Original filing |
| Tudor Investment | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 11657753.00 USD | 543485.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 6495060.00 USD | 302800.000000 | Shares | add | Original filing |
| Polen Capital Management | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 2197703.00 USD | 102457.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1603001.00 USD | 74732.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | ADAPTIVE BIOTECHNOLOGIES COR | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 859866.00 USD | 40087.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.